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Ischemically injured reperfused myocardium is character- 
ized by increased 18F-lluorodeoxyglucose uptake as demon- 
strated by positron emission tomography. To elucidate the 
metabolic fate of exogenous glucose entering reperfused 
myocardium, D-[6-r4C] glucose and L-[U-13C] lactate were 
used to determine glucose uptake, glucose oxidation and the 
contribution of exogenous glucose to lactate production. 
The pathologic model under investigation consisted of a 3 h 
balloon occlusion of the left anterior descending coronary 
artery followed by 24 h of reperfusion in canine myocar- 
dium. The extent and severity of myocardial injury after 
the ischemia and reperfusion were assessed by histochemi- 
cal evaluation (triphenyltetrazolium chloride and periodic 
acid-Schiff stains). Thirteen intervention and four control 
dogs were studied. 
The glucose uptake in the occluded/reperfused area was 
significantly enhanced compared with that in control dogs 
(0.40 f 0.14 versus 0.15 + 0.10 ~mol/ml, respectively). In 
addition, a significantly greater portion of the glucose 
extracted immediately entered glycolysis in the intervention 
group (75%) than in the control dogs (33%). The activity of 
the nonoxidative glycolytic pathway was markedly in- 
creased in the ischemically injured reperfused area, as 
evidenced by the four times greater lactate release in this 
area compared with the control value. The dual carbon- 
labeled isotopes showed that 57% of the exogenous glucose 
entering glycolysis was being converted to lactate. Exoge- 
nous glucose contributed to >90% of the observed lactate 
production. This finding was confirmed by the histochem- 
ical finding of sustained glycogen depletion in the occlusion/ 
reperfusion area. The average area of glycogen depletion 
(37%) significantly exceeded the average area of necrosis 
(17%). 
These data demonstrate enhanced and sustained activity 
of the nonoxidative glycolytic pathway after a prolonged 
occlusion with reperfusion in canine myocardium. Because 
glycogen stores remain depleted, exogenous glucose be- 
comes an important myocardial substrate under these 
pathologic conditions. 
(J Am Co11 Cardiol1989;13:745-54) 
Reperfusion to salvage ischemically injured myocardium has 
recently become the focus of experimental and clinical 
research (l-5). It is known that regional myocardial function 
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remains impaired for a prolonged period after ischemia, even 
in reversibly injured myocardium (6). In addition, it has been 
shown that the delayed functional recovery is paralleled by a 
sustained decrease in the tissue concentration of high energy 
phosphate, indicating abnormalities in myocardial energy 
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metabolism (7). Recent studies (8,9) addressing substrate 
metabolism in reperfused myocardium have demonstrated 
delayed recovery of fatty acid oxidation even after short 
periods of ischemia. 
Increased glucose utilization has been observed during 
myocardial ischemia and hypoxia (10). More recent animal 
and clinical studies (11-13) using radiotracers have demon- 
strated a similar metabolic pattern in reperfused myocar- 
dium. In the canine model, sustained abnormalities in 
“C-palmitate kinetics in post-ischemic myocardium were 
matched by increased “F-fluorodeoxyglucose (18F-deoxy- 
glucose) uptake, suggesting increased use of exogenous 
glucose in the presence of impaired fatty acid metabolism 
after reperfusion ( 11). 
Because “F-deoxyglucose traces only transmembrane- 
ous transport and phosphorylation of glucose, limited infor- 
mation about glucose metabolism can be derived from the 
use of this tracer. To define the metabolic fate of exogenous 
glucose taken up in ischemically injured reperfused canine 
myocardium, the relative contributions of oxidative and 
nonoxidative glucose utilization were assessed by a dual 
carbon-labeled isotope technique using D-[6-‘4C] glucose 
and L-[U-13C] lactate. Exogenous glucose oxidation based 
on 14C-labeled carbon dioxide (r4C0,) production and the 
isotopically measured lactate release were quantified. In 
addition, the contribution of exogenous glucose to lactate 
production was determined. We employed histochemical 
techniques to independently define the extent and severity of 
myocardial injury in the occlusionlreperfusion area and to 
correlate biochemical findings with the morphologic mani- 
festation of ischemic injury in that area. 
Methods 
Study protocol and animal preparation. Nineteen adult 
mongrel dogs weighing 21.5 to 32.5 kg were studied during a 
2 day protocol (Fig. 1). On day 1, after fasting overnight, the 
animals were anesthetized with sodium thiamylal (Surital) 
and ventilated with a mixture of oxygen and room air to 
maintain a partial pressure of oxygen in the arterial blood 
>lOO mm Hg. Under sterile conditions, the left carotid 
artery was isolated by a cutdown procedure and a 7F 
catheter was advanced under fluoroscopic guidance into the 
ostium of the left anterior descending coronary artery for 
insertion of a 3F Fogarty balloon catheter. The balloon tip 
was placed distal to the first diagonal branch, which was 
identified by injection of contrast medium. The balloon was 
inflated with a mixture of saline solution and contrast me- 
dium, and occlusion of the left anterior descending artery 
was verified by repeat injections of contrast medium. Three 
hours after establishment of occlusion, the balloon catheter 
was slowly deflated, and both catheters were removed. The 
carotid artery was then ligated and the cutdown site closed. 
During ischemia and reperfusion, the electrocardiogram 
DAY 1 
Balloon Occlusion of LAD (3 hrs) 
Reperfusion 
DAY 2 
Thoracotomy 
Microsphere Blood Flow 
1% Glucose Infusion 
13C Lactate Infusion 
A-V Sampling 
Microsphere Blood Flow 
Sacrifice 
TTC Stain 
PAS Stain 
Tissue Counting (1sF) 
Figure 1. Study protocol of Day 1 and Day 2. LAD = left anterior 
descending coronary artery; TTC = triphenyltetrazolium chloride 
stain; PAS = periodic acid-Schiff stain. 
(ECG) was continuously monitored. Before occlusion, an 
intravenous bolus of lidocaine (50 mg) was given, followed 
by constant infusion (2 mglmin). After reperfusion, the dogs 
received a single dose of procainamide (150 mg) intramus,- 
cularly. Fifteen dogs underwent coronary occlusion, to 
serve as controls, four dogs were subjected to the same 
study protocol, but no occlusion was performed. 
On day 2, approximately 24 h (range 16 to 36 h) after 
reperfusion, all dogs were re-anesthetized, and a left thora- 
cotomy was performed. The pericardium was widely incised 
and sutured to the chest wall to form a cradle in which the 
heart was suspended. To inject microspheres and sample 
arterialized blood, a polyvinyl cannula was inserted into the 
left atrium. To obtain blood samples from a vein draining the 
territory of the left anterior descending artery and the entire 
heart, two 23 gauge butterfly needles were inserted; one into 
a vein parallel to the left anterior descending artery, distal to 
the site of the balloon occlusion and one into the coronary 
sinus under the left atria1 appendage. An additional catheter 
was placed into the femoral artery to monitor blood pressure 
and to withdraw blood for microsphere calibration. 
Complete metabolic andjow data were obtained in all 4 
control dogs but in only 13 of the 15 intervention dogs. This 
report is based on the data from these 17 animals (4 control 
and thirteen intervention). 
D-[6-14C] glucose and L-[U-‘3C] lactate. After thoracot- 
omy and instrumentation, D-[6-14C] glucose (New England 
Nuclear; specific activity 56.1 mCi/mmol) was administered 
as a priming bolus of 24 &i, followed by intravenous 
infusion at a constant rate of 15 &i/h. To determine the 
myocardial lactate isotopic uptake, amount of lactate re- 
leased and amount of glucose being converted to lactate, 
the stable (non-radioactive) isotope L-[U-13Cllactate 
(Merck, Sharpe & Dohme L-[U-‘3C] sodium lactate; 99% 
isotopic purity) was simultaneously infused. To achieve a 
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steady arterial level of L-[U-‘3C] lactate (1.5% to 2.0% of the The coefficient of variation for specific activity of lactate was 
circulating chemical lactate), a priming dose of 30 mg of 2.5% in our laboratory (six analyses of one sample). The 
13C-lactate was introduced intravenously over 2 min, fol- 14C0, was collected directly from blood by a previously 
lowed by an intravenous infusion of the isotope at a constant established diffusion method having a 2.9% coefficient of 
rate of 35 mg/h. variation (14,16). 
Equilibration of these tracers in arterial and myocardial 
venous blood is known to occur in 20 to 25 min after 
initiation of the infusion (14,15). At that time, blood samples 
were drawn simultaneously from the left atrium (for the 
arterial sample), the coronary sinus and the vein draining the 
territory of the left anterior descending artery to measure 
arteriovenous differences across the reperfused area as well 
as in the territory drained by the coronary sinus. Thirteen 
dogs (4 of 4 control and 9 of 13 intervention) received an 
infusion of D-[6-‘4C] glucose and L-[Ut3Cl lactate. Three 
sets of arteriovenous samples from four control and nine 
intervention dogs were drawn 10 min apart. 
L-[U-‘3C] lactate analysis. L-[U-‘3C] lactate content was 
determined with use of gas chromatography/mass spectrom- 
etry (16,17). Lactic acid was separated by ion exchange 
chromatography, converted to a volatile derivative (the 
trimethylsilyl ether of methyl lactate), and ion currents were 
recorded at m/e 161 and 164 and the results were compared 
with a standard curve (16). All isotopic and chemical analy- 
ses were performed in duplicate. 
To determine the amount of lactate oxidation in this 
occfusionireperfusion model, the remaining four interven- 
tion dogs received a priming bolus of 20 &i of L-[1-‘4C]- 
lactic acid (New England Nuclear Corp.; specific activity 55 
mCi/mmol) followed by constant intravenous infusion at a 
rate of 25 &i/h. After an equilibration period of 25 min (16), 
arterial and venous samples were withdrawn as outlined to 
determine concentrations and specific activities of lactate 
and glucose, as well as 14C02 content. 
Calculations. This investigation used glucose labeled in 
the sixth carbon position. This carbon is released as 14C0, in 
the citric acid cycle. By measuring the venous-arterial (V-A) 
14C02 difference, the amount of glucose being oxidized 
(pmol/ml blood) can be calculated as: 
(V-A) “C02 dpmiml blood 
arterial specific activity of glucose’ 
in which dpm = disintegrations per minute. 
Chemical analysis. Weighed blood samples were ana- 
lyzed for chemical concentrations of glucose, lactate and 
nonesterified fatty acids, as well as for 14C0, content and the 
specific activities of glucose and lactate (14,17). Samples 
from the dogs receiving 13C-lactate were also analyzed for 
13C-lactate enrichment. Those samples to be analyzed for 
lactate, glucose, specific activities and 13C-lactate were 
mixed immediately with a measured volume of cold 7% 
perchloric acid and centrifuged; the protein-free supernatant 
was then separated and stored at -4°C. Lactate and glucose 
concentrations were determined later by enzymatic spectro- 
photometric methods on this protein-free fluid (14,16). Free 
fatty acids were determined with a spectrophotometric 
method (18). Blood oxygen content was measured with use 
of an oxygen analyzer (Corning 920) (19). 
When [6-14C] glucose is used as a tracer, other substrates 
such as lactate become labeled secondarily. Therefore, 
before the oxidation rate of glucose is calculated, the V-A 
14C02 value must be corrected for the oxidation of second- 
arily labeled substrates (14,16). As outlined, four of the 
intervention dogs received [1-‘4C] lactate to determine the 
oxidation rate of lactate under these occlusionlreperfusion 
conditions. In these dogs, 78 2 4% of the isotopically 
measured lactate uptake in the coronary sinus samples and 
79 5 6% of that in the left anterior descending venous 
samples were oxidized. These values were applied, together 
with the 13C-lactate extraction ratio and the arterial specific 
activity of secondarily-labeled lactate, to correct the ob- 
served 14C02 production for the oxidation of secondarily- 
labeled lactate. The corrected 14C02 production was then 
used with the specific activity of glucose to calculate the 
oxidation of exogenous glucose. 
The chemical extraction ratio (%) for a given substrate 
was calculated from the arterial and venous chemical con- 
centrations as: 
D-[6-‘4C] glucose analysis. Glucose, lactate and pyruvate 
were separated by ion exchange chromatography as previ- 
ously described by Wisneski et al. (14). The protein-free fluid 
was neutralized and passed successively through cation and 
anion exchange columns to remove labeled ionic com- 
pounds. Portions of the eluates containing glucose in H,O 
and lactate in 0.25 M sodium acetate were assayed by the 
described enzymatic methods. Other portions were mixed 
with Aquasol (New England Nuclear), and the 14C content 
was measured in a scintillation counter. Results of scintilla- 
tion counting were expressed as disintegrations per minute 
(dpm), and the specific activity was calculated as dpmlkmol. 
in which [A] = arterial blood concentration and [V] = 
coronary sinus or left anterior descending venous blood 
concentration. 
The isotope or [U-‘3C] lactate extraction ratio (%‘o) was 
calculated from the concentration of [U-‘3C] lactate in the 
artery and vein as: 
[A] x % 13C3 in artery - [VI x % 13C3 in vein x ,oo 
[A] x % 13C3 in artery 
in which, 
*(soo.o > d) al!s %ugdum snu!s K.IEUO.IO~ 
aql U! Il?ql UEql ‘JaMOl %CI SBM KJOj!JJa$ pasnpadaJ aql 
u! uo!peqxa ua%Kxg .(roo*o > d) KJalJe %u!pua%ap Jopaw 
13al aql30 hrol!JJal aqj u! pun03 leql uvql Jaq%!q KpuE3y!u%!s 
SBM q3!q~ ‘~w/~ourr/ ~1.0 + ~z.0 pa%JaAB snurs KJeuoJo:, 
aql u! uo!peJ$xa alt?lDt?T *KJaw %u!pua3sap Jo!Jaw l3al aql 
30 KJol?JJal aql u! sSop au!u aql3o ualzas u! uo!pnpoJd aF?Pq 
lau qq~ ~ur/~ouITI ~1.0 + ~0.0 pa%JaAe pue Klap!M paveA 
uogDeJlxa alew27 ‘(so.0 > d) AJaw bpuawap Jopaw 13al 
aql %yallE?J~d u!aA aql U! JaMOl %91 SBM Sp!Dr! /(Ill?3 30 UO!$ 
-3eJlxa seaJaqM ‘(so*0 > d) aldures poolq snugs KJWIOJO:, aql 
u! leg1 ueql Jay%q %og SBM K.Iaw k?u!puaDsap Jopaw l3aI 
aql30 KJolval aql u! uog3eJlxa asocrq% ‘s8op uo!luaAJalu! 
au!u aql UI *KlaA!padsaJ ‘$459 put! %LI pa%JaAe Ua%KXO pw 
alvpej 30 uo!lczJlxa aqL *ohz9 30 uo!peJlxa snouaAoualJe ue 
paleaAaJ sppe Kng payualsauou 30 uogeu!wJalap seaJaqM 
‘wrupJwoKru aq1 Kq papwlxa S’I?M asoz@ 30 gz Kluo 
.paJadtuo3 aJaM sal!s aldwes snugs KJBUOJO~ pua u!aA K.Ial 
-JB %u!puaDsap Jopaw l3aI aql uaqM suogDeJ]xa alwlsqns 
u! saDuaJag!p ~2ay!u8!s ou aJaM aJay ‘s%op lo~luo:, Jno3 
aql uI ‘1 a\qtzL u! palsy aJe sawqsqns @np!A!pu! 30 suogeJ1 
-ua3uo3 u! sa3uaJagp snouaAo!Ja)Jt! Kq pau!wJalap suog3eJl 
-xa IwpJe~oKur aqL 3alaqsqns ~0 uog3aqxa pqpra3oob~ 
*MOB poolq 30 suo!wu!urJalap 
puo3as put! IsJy aql uaaMlaq sawaJag!p lue3y!u%!s ou aJaM 
aJaqJ ‘(IO@0 > d ft?aJE JOgSOd ~!uIaq3s!uou aql u! MOB aql 
30 %,g) ysrl30 eaJe aql u! 8 ~1 Jad ug.u/~u~ p’sc T 8’99 pue 
Ill?M JO!JalSOd aql U! 8 001 Jad U!UJ~Ul 2.62: 7 Z’L8 pa%JaAE 
MOy pOOIq ‘SlW.I!UE UO!~UaAJalU! aql UI ‘(SN) IlEM JO!JalSOd 
aq1 U! 8 001 lad u~uJflw 81 ? p6 pue KJa&lE bpua3sap 
Joualue 33aI aq1 30 KJol!JJal aql u! 8 001 Jad u!ur/pu pi 
T 96 pa%JaAt? MOy pOOlq ‘S%Op lOJlUO:, JnO3 aql UI %aldunzs 
poolq pJ!ql pue puoDas aql uaaMlaq pue 1s~~ aql aJo3aq 
paU!UIJalap SBM MOy pOOIq lE!pJt?DOKM *popad %uqdr_ues 
poolq aql %u!Jnp salqegglz asaqi u! safjwq:, ~ue~y!u%!s ou 
aJaM aJaqL *u!m/swaq 11 T 8~130 awJ way a8eJaAo UE ql!M 
8H UJUJ PZ T PZI pa%?JaAE S%Op II?? U! aJnSSaJd pOOIq %lOlSKS 
aqj ‘Kruolomoq~ aqj Jalp K~awpaunu! pue UogJadaJ 
Jal3E q pz Iv wuamamseaur MO! poolq putr 3gauhpowaH 
wnsw 
.slas elep uaaMlaq saDuaJa33!p au!unalap 
01 pasn aJaM Isal I paJ!Pd aql pua a3ut+?A 30 saslipuv 
‘as + ueaw e se passaJdxa aJTi? wz?a ~!shleua la3!$+?@ 
wnpJwoKru s!uraqas!uou aql 
u! put! ysu 30 seaJe aql u! joy poolq awlnD]e:, 01 pasn aJaM 
%uluno:, IIaM Kq pau!ruJalap suoykzJwa~u0~ Kl!hyz anssg 
jeuo!%aJ pue ‘pa8wam a.m4 s~uaruamseatu qlo8 *saIdrues 
poolq p.uqI put2 puo9as aqi uaaMlaq pue 1s~~ aql aJo3aq 
pau!ejqo aJaM s~uawamsearu MOM poola *(u!ru/~w 6’~) KJalJe 
@Jotua3 aql way uhmpqj!m IBM aldrues amaJa3aJ pyalre ue 
‘KIsnoaueqnuus wnpw l3aI aql olu! papafu! (Klalzg3adsa.t 
‘ah ‘“315 
‘u&,~) u+Iaz put? uIn!uIoJq~ ‘~9 30 SaJaqds 
-OJ~!UI palaqej Kl!~!l~t?0!peJ 30 asn ql!M pau!ruJalap SAM 
MOy pOOIq IwPJEDOKLU IWJO!%a~ ‘MOy pOOlq [t?!p.IkDOoh&+l 
‘(au) aaJq$ pUE (svd) Z SUO!paS SSOJ3 30 SXX3JIlS 
lua3t?fpe aql uo paJI?dIUOD aJaM uogaldap ua%o3K$l put? 
slsoJ3au 30 sBaJv aqL *uo!pas sso~3 aql30 eaJa aql30 lua:, 
-Jad e se passaJdxa SBM ~uaruamsaaw q3ea pue Ja~aU.Ig?ld 
s3!uoLunN e 30 asn ql!M ‘sapqs UJOJ~ KJlatu!ut?ld Kq pamst?auI 
aJaM (aAge%au ~JJ) s!somau pm (an!R?%au svd) uoyaldap 
ua8oDK[% 30 SeaJB aqL *S!SOJ~~U anssg 30 uo!~e~y!luap! 
Jo3 @U Oz Jo3 &‘E le z.I,LL) ap!Jolq:, ~n!~oz~JwKuaqdpl U! 
paltqn3u! alah s pue f ‘1 suo!pas sso~s *(svd) gq3s-p!Dz 
g!pOpad ql!M paup?ls Kpuanbasqns put? a~!]t?xy s,Kou~e3 
u! pasJauIw! Klawpaww! alaM p pm z SuogDas SSOJ~ ‘y%q] 
~13 1 qXa ‘suo!pas SSOJD alzy OJU! In3 pm pas!Dxa Klp!dw 
SBM ueaq aqJ .KJa&IE %u!pUaDSap JO!Ja)Ul? l3al aql30 KJOluJal 
.u2pmeA aql auqlno 01 wnpje i3aI aqj olu! paiDa@! SBM anlq 
~e~w?uow ‘Klsnoauallnuus *apuolq3 urn!sselod 30 uo!pa[u! 
snouamqu~ ut2 qj!M palI!y aJaM s8op aqJ, wuapa Jeln:, 
-SEA!Jad Kq pay!luap! aq Kl!sea ppIoD q3!qM ‘uo!~~?yu! uoollt?q 
aqj 30 aqs aqj je paprqmo SBM KJalJ’t! %u!puaDsap ~oualw 
l3aI aq] ‘1uauIpadxa qDea 30 pua aql 1~ *kIppIIaq3o@H 
:sv pauynalap 
adaM poojq Jo pulalt_wvl 01 anp wdp lvcyanoayj ayl 
:SV pawlnyv3 adahi 
poolq snouanjo pyalv]DvlJo zudp panAasqo JO pwwv aqL 
(*alolDel30 SajnDaloru 0~1 sp]a!K aSOl?@ 
30 almalow au0 a,snmaq pasn s! z 30 Jolz3 aql ]EqJ aioN) 
asoX+ [rz!~al~e JO Kl!~!pe Dy!Dads 
‘2 x 
uph u! poolq ~w/a~epej urdp (~e3!~aJoaq~-pa~Jasqg) 
:SB 
asom@ Isuaut! 30 KJ!A!PE Dypads aqt put! u!aA aql u! poolq 
30 Iru/aleiXj 30 (rudp) alnu!w Jad suo!wJ%aiu!s!p p?DyaJoaqi 
put! paAJasq0 aql woq palvp2lvJ sv~ pasnpodd .io pasvalar 
aivizy ayj 0~ aso@ snouaSoxa Jo uopnqyuo3 aqJ 
‘([AI - [VI) - avdn ww I&,-nl 
:sv palvpfDlv3 SVM wnp_iv2olCzu ayr Xq pasnp 
-and 10 pasvalal (poolq pu~~ozurl) aitwvl Jo !unotuv ayl 
001 
‘oge~ uogswlxa aiepel [aE,-n] 
x [VI 
:SV anb?uysa] adolos! ayl Xq paupu 
-Aaiap sv~ (poolq pu1~0w1I) ayvidn aiwvl 1v~p~v3oX~ 
*(KgaruoJ13ads 
sswu~Kqd~J%olemoJq~ se% ruoq Kp3aJ!p paugqo s! E&, %) 
aiepel p9!waq9 
‘001 x 
aiwV3,1 
= QE, % 
JACC Vol. 13, No. 3 
March 1, 1989:745-54 
SCHWAIGER ET AL. 749 
GLUCOSEMETABOLlSMINREPERFUSEDMYOCARDIUM 
Table 1. Chemical Substrate Extraction in Control and Table 2. Exogenous Glucose Utilization Measured by 
Intervention Animals “C/‘3C Analysis 
Coronary 
Arterial LAD Vein Sinus 
Level Extraction Extraction 
Control (n = 4) 
Glucose 5.88 + 0.85 0.15 4 0.10 0.10 ? 0.05 
(~mol/ml) (2%) (2%) 
NEFA 0.38 c 0.06 0.22 t 0.13 0.25 + 0.11 
(~mol/ml) (58%) (66%) 
Lactate 1.08 ? 0.60 0.20 ? 0.15 0.16 + 0.09 
(~mol/ml) (19%) (15%) 
Oxygen 8.66 + 0.49 5.51 + 0.36 5.65 f 0.67 
(~mollml) (64%) (66%) 
Intervention (n = 9) 
Glucose 4.38 ? 0.43 0.40 2 0.14 0.26 + 0.13 
(~mol/ml) (%) (6%)* 
NEFA 0.79 2 0.25 0.32 + 0.12 0.38 2 0.09 
(~mol/ml) (40%) (48%)* 
Lactate 1.06 t 0.50 0.02 t 0.15 0.23 * 0.17 
(~LmoVml) (2%) (22%)* 
Oxygen 8.81 ? 0.82 5.06 + 1.16 5.80 + 0.94 
(~mollml) (57%) (66%)* 
*p < 0.05; paired t test comparing left anterior descending (LAD) vein and 
coronary sinus sample. NEFA = nonesterified fatty acids. Numbers in 
parenthesis represent chemical extraction fraction expressed in percent. 
Control Intervention Animals 
Animals (n = 9) 
(n = 4): 
LAD LAD CS 
Glucose extraction (pmol/ml) 0.15 + 0.10 0.40 2 0.14 0.26 ? 0.13* 
(100%) (100%) (100%) 
Exogenous glucose entering 0.05 + 0.02 0.30 + 0.05 0.17 -c 0.06* 
glycolysis (~moliml) (33%) (75%) (65%) 
Exogenous glucose to lactate 0.01 5 0.01 0.17 5 0.05 0.08 + 0.02* 
(6%) (43%) (31%) 
Exogenous glucose oxidized 0.04 + 0.05 0.13 2 0.08 0.09 + 0.07 
(27%) (32%) (34%) 
Lactate release (~moliml) 0.08 + 0.03 0.37 2 0.11 0.20 2 O.ll* 
*p < 0.05 as compared with left anterior descending venous extraction 
(LAD) vein in intervention animals. CS = coronary sinus extraction. The 
percentages in parentheses reflect the amounts relative to glucose uptake. 
artery segment (0.37 -+ 0.11 ~mol/ml) was in close agreement 
with the amount of exogenous glucose converted to lactate 
(0.17 ? 0.05 pmol/ml), because one molecule of glucose is 
converted to two molecules of lactate. These metabolic data 
demonstrate that exogenous glucose accounts for most of 
the lactate release or production in this pathologic model. 
Fate of extracted glucose. Tracer determinations of exog- 
enous glucose oxidation and glucose conversion to lactate 
were related to overall extraction of glucose (Table 2). In the 
four control dogs, there were no significant differences in 
glucose utilization when the left anterior descending artery 
vein and coronary sinus samples were compared. Twenty- 
seven percent of exogenous glucose was being oxidized, 
whereas 6% were converted to lactate. Presumably the 
remainder (67%) entered a glucose storage pool, that is, 
glycogen. 
The results from the intervention group revealed a df- 
ferent metabolic pattern. Exogenous glucose extraction was 
significantly increased compared with that of the control 
group. The amount of exogenous glucose entering glycolysis 
was also significantly increased, as evidenced by 14C0, 
production or 14C-lactate in the venous effluent (75% in the 
vein paralleling the left anterior descending artery and 65% 
in the coronary sinus) (Table 2). 
Correlative findings. Neither the circulating glucose nor 
lactate arterial levels correlated significantly with the respec- 
tive myocardial substrate extractions in this study. How- 
ever, nonesterified fatty acid plasma levels correlated signif- 
icantly with fatty acid extraction measured in the vein 
paralleling the left anterior descending artery (r = 0.6; p < 
0.05) and in the coronary sinus (r = 0.74; p < 0.02; Fig. 2). 
Furthermore, fatty acid plasma levels were inversely related 
to the amount of glucose oxidized in the left anterior 
descending vein (r = -0.69; p < 0.01) and coronary sinus 
(r = -0.61; p < 0.05). There were no significant correlations 
between lactate or glucose blood levels and the relative 
amounts of glucose oxidized or that released as lactate. In 
the territory of the left anterior descending artery, the 
amount of glucose converted to lactate and exogenous 
glucose oxidized were both significantly related to glucose 
extraction (r = 0.83, p < 0.002 and r = 0.79, p < 0.004, 
respectively) (Fig. 2). 
The amount of glucose converted to lactate averaged 0.17 
-t 0.05 ~mollml in the territory of the left anterior descend- 
ing artery; this was significantly higher (p < 0.001) than that 
in the coronary sinus (0.08 + 0.02 ~mollml). However, the 
amount of glucose oxidized in both sample sites did not differ 
significantly (0.13 t 0.08 versus 0.09 + 0.07 ~mol/ml). 
Lactate release derived from ‘3C-lactate data was signifi- 
cantly higher (p < 0.002) in the reperfused segment (0.37 2 
0.11 PmoYml) than in the coronary sinus site (0.20 4 0.11 
pmol/ml). The lactate release in the left anterior descending 
Histochemistry. Examples of the histochemical results 
are shown in Figure 3, which compares two adjacent cross- 
sectional stains from a control and an intervention dog. The 
stained tissue of the control dog shows homogeneous stain- 
ing with periodic acid-Schiff (PAS) and triphenyltetrazolium 
chloride (TTC). For the intervention dog, the TTC stain 
shows a pale area of necrosis, whereas tissue with intact 
glycogen stores appears pink on the PAS stain and glycogen- 
depleted areas are not stained. In this dog the area of 
glycogen depletion was approximately 50% of the cross 
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Figure 2. Substrate utilization in the reperfused myocardium. A, 
Plasma level of non-esterified fatty acids (NEFA) and regional 
extraction of nonesterified fatty acids in the left anterior descending 
coronary artery territory; B, Nonesterified fatty acid plasma levels 
and amount of 14C glucose oxidized; C, Glucose extraction and 
amount converted to 14C lactate; D, Glucose extraction and amount 
of exogenous glucose oxidized. 
section and exceeded the nonstained area on the ‘IX stain 
(22%). In all intervention dogs, the areas of necrosis aver- 
aged 17.4 + 10.5% of the mid-ventricular cross section, 
which was significantly smaller than the average glycogen- 
depleted area of 36.6 t 19.2% (p < 0.001) (Fig. 4). In all four 
control dogs there was no evidence of necrosis or glycogen 
depletion. 
Discussion 
This study demonstrates for the first time that the activity 
of nonoxidative glucose pathway is enhanced at 24 h of 
reperfusion after a prolonged (3 h) ischemic injury. Our 
observation that lactate released by reperfused myocardium 
is predominantly derived (HO%) from nonoxidative metab- 
olism of exogenous glucose was supported by the histochem- 
ical finding of sustained glycogen depletion in tissue sur- 
rounding the area of necrosis. Previous studies (11) have 
shown that the myocardial injury in this setting is reversible, 
that is, areas of enhanced glucose extraction measured by 
‘*F-deoxyglucose and positron emission tomography (PET) 
are associated with reversible wall motion abnormalities. 
Therefore, these data imply that exogenous glucose is very 
important for the functional recovery of the metabolically 
compromised tissue after occlusion and reperfusion. 
Methodologic Considerations 
Animal model. We chose a dog model that reproduces 
the clinical setting of acute myocardial infarction and reper- 
fusion. In this model, we recently demonstrated (11) that 
PET measurements of increased “F-deoxyglucose uptake 
after 24 h of reperfusion predict reversible tissue injury as 
confirmed by subsequent functional recovery. A period of 24 
h after reperfusion was chosen because previous serial 
studies in the same model (20) indicated that maximal 
‘8F-deoxyglucose uptake occurs at that time. 
The disadvantage of the relatively long period of ischemia 
is the significant, but varying amount of necrosis that occurs 
in this model. However, independent of the duration of 
ischemia, the degree of ischemia in a vascular territory 
varies as a function of heterogeneous regional flow reduction 
and oxygen demands. Many previous investigations (21,22) 
indicated a “wave front” characteristic of myocardial necro- 
sis during coronary occlusion with progression from suben- 
docardium to subepicardium within relatively definite lateral 
borders. Unfortunately, there is, to our knowledge, no in 
vivo animal model producing homogeneous ischemic injury 
in an occluded vascular territory that could specifically 
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define the metabolic pattern in reversibly injured myocar- 
dium. 
The heterogeneity of ischemic injury makes the interpre- 
tation of metabolic data derived from arteriovenous sam- 
pling more dificult. Because the accurate definition of the 
territory drained by a given coronary vein is limited, we 
chose to compare two venous sample sites. A vein parallel- 
ing the left anterior descending artery distal to the occlusion 
site was used for blood samples relating to the region of 
reperfused ischemic myocardium. To contrast these regional 
results with global myocardial metabolism, additional ve- 
nous samples were obtained from the coronary sinus. This 
latter site does not represent a true control site because the 
coronary sinus drains blood from the entire heart and, 
therefore, contains mixed venous blood from reperfused 
injured and normal myocardium. However, the significant 
differences we observed between these two sample sites 
indicate a unique metabolic pattern in the reperfused seg- 
ments. In addition, comparison with our data from dogs 
Figure 3. Two examples of triphenyltetrazolium chloride and peri- 
odic acid-Schiff stains. A, Control animal without intervention 
showed homogeneous staining after TTC (below) and PAS (above). 
B, Intervention animal with a large TTC negative area (below) that 
identifies areas of necrosis (22% of left ventricle cross section). The 
area of glycogen depletion (PAS negative) (above) is 50% and 
exceeds the area of necrosis in this section. 
undergoing the same experimental protocol without coro- 
nary occlusion further confirms the regional metabolic ab- 
normalities assessed in the intervention group. 
Because of the difficulty in determining post mortem the 
exact extent of myocardium drained by a specific vein, 
correlation of data derived from arteriovenous sampling with 
data from tissue assays and microsphere blood flow deter- 
minations is limited. Therefore, we did not calculate regional 
substrate consumption, which depends on exact measure- 
ments of drained tissue volume and blood flow. 
Histoehemistry. Standard staining techniques for detect- 
ing necrosis (TTC) and glycogen tissue content (PAS) (23) 
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Figure 4. Histochemical stains. Summarized results of relative ex- 
tent of necrosis as identified by triphenyltetrazolium chloride (TTC) 
and glycogen depletion by periodic acid-Schiff (PAS) negative in a 
mid-left ventricular (LV) cross section. 
were employed to characterize the extent and severity of 
ischemic injury in the experimental animals. The histochem- 
ical results based on these two stains were calculated from 
cross-sectional surfaces directly facing each other and only 
microns apart so that comparison of respective nonstained 
areas was possible. Although both staining methods allow 
only qualitative evaluation of relative differences, these 
methods have been validated and proved practical in many 
experimental studies (23). 
The histochemical results in this study verify the previ- 
ously described heterogeneity of the ischemic injury; that is, 
necrotic, glycogen-depleted and histochemically normal tis- 
sue coexisting in the risk area. In most intervention dogs the 
necrotic zone was confined to the subendocardial layers, 
whereas glycogen depletion appeared to extend transmurally 
and significantly exceeded the area of necrosis. The course 
of glycogen depletion over time, has been fully characterized 
during ischemia (24), but little information is available about 
restoration of myocardial glycogen after reperfusion. The 
sustained depletion noted in our study contrasts with the 
reported (25) rapid recovery of glycogen stores after short 
periods of ischemia in heart or peripheral muscle. 
Data Interpretation of Metabolic Results 
Oxidative and nonoxidative glycolysis. The results of this 
study confirm previous PET studies in the same experimen- 
tal model showing increased exogenous glucose extraction 
by the reperfused myocardium (11,20). After uptake by the 
myocyte, glucose can follow several metabolic pathways: 
oxidation through the citric acid cycle, storage as glycogen, 
utilization in the hexose monophosphate shunt pathway and 
conversion to lactate through the glycolytic pathway (26). 
Using [6-i4C]glucose and measuring the myocardial produc- 
tion of 14C02 enabled us to quantify the amount of exoge- 
nous glucose undergoing rapid oxidation, because carbon in 
the sixth position is released during oxidation in the citric 
acid cycle (26). The simultaneous infusion of [U-‘3C]lactate 
and [6-‘4C]glucose allowed us to calculate the amount of 
lactate being released and the conversion of exogenous 
glucose to lactate through glycolysis. Thus, in this study we 
were able to quantitate the metabolic activity in two of the 
glycolytic pathways: oxidation and nonoxidative glycolysis. 
Myocardial oxidative metabolism in normal myocardium. 
In the control dogs, only a small amount of glucose was 
extracted by myocardium, confirming numerous previous 
studies demonstrating that nonesterified fatty acids are the 
primary substrate of myocardial oxidative metabolism in the 
normal heart. In addition, only about 30% of 14C activity 
entering the cell as glucose was recovered in the effluent as 
14C02 or 14C-lactate in the control dogs. This finding sug- 
gests that the remaining 70% of labeled substrate entered a 
slow turnover pool that has not been equilibrated during the 
25 to 35 min of [6-r4C] glucose infusion. In agreement with 
previous results obtained in the human heart using the same 
isotope technique (14), these observations indicate that the 
majority of glucose uptake in the fasting state is used to 
maintain tissue stores of glucose, such as glycogen. Turn- 
over estimates of 5 to 6 h for the myocardial glycogen pool 
would support this hypothesis (27). 
Exogenous glucose utilization in iscbemic myocardium. In 
the intervention dogs, we observed a different pattern of 
exogenous glucose utilization. There were significant in- 
creases in glucose extraction and decreased extractions of 
fatty acids and oxygen compared with values in the control 
dogs (Tables 1 and 2). In contrast to the control dogs, in the 
intervention group 75% of the extracted glucose was ac- 
counted for by the 14C-lactate and 14C02 in the venous 
effluent draining the reperfused segment. This finding sug- 
gests increased glycolytic flux with either reduced glycogen 
synthesis or a smaller glycogen pool having a higher turn- 
over rate. Both hypotheses are consistent with the histo- 
chemical findings of sustained glycogen depletion in the 
reperfused myocardium. In addition, most of the lactate 
produced by the injured myocardium in this preparation 
(~90%) was derived from exogenous glucose. This hypoth- 
esis also agrees with the histochemical evidence of regional 
glycogen depletion in the risk area. Thus, this occlusion/ 
reperfusion preparation differs from the experimental mod- 
els of acute ischemia in which glycogen has been shown to 
be the major source of myocardial lactate production (24). 
Prolonged nonoxidative glycolysis in reperfused myocar- 
dium. In the reperfused myocardium, 57% of the glucose 
entering glycolysis was converted to lactate. This amount 
was considerably more than that of glucose to lactate con- 
version in the control dogs (18%). The calculated lactate 
release was more than four times greater in the reperfused 
myocardium of the intervention animals than that in the 
control myocardium. These findings are consistent with 
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sustained and enhanced activity of the nonoxidative glucose 
pathway. Nonoxidative glycolysis has been observed pri- 
marily during acute ischemia and hypoxia and is thought to 
reflect compensatory nonoxidative high energy phosphate 
production in the presence of impaired oxidative metabolism 
(10,24,28). To our knowledge, this study demonstrates for 
the first time that nonoxidative glycolysis can be maintained 
for prolonged time periods after an ischemic insult, The 
significant correlation of glucose extraction, lactate produc- 
tion and glycogen depletion suggests the dependence of 
nonoxidative metabolism on the availability of exogenous 
glucose in this pathologic setting. 
An additional source of nonoxidative glycolysis may be 
leukocytes that infiltrate ischemically injured myocardium 
(29). However, recent studies showed that “F-deoxyglucose 
distribution in reperfused myocardium differs from that of 
“‘Indium-labeled leukocytes, which indicate that increased 
‘8F-deoxyglucose uptake in reperfused myocardium pre- 
dominantly traces myocyte metabolism (30). 
Coexistence of oxidative and nonoxidative pathways in 
repel-fused myocardium. In addition to contributing to the 
lactate production, about 40% of the exogenous glucose 
entering glycolysis was oxidized in the reperfused myocar- 
dium. The coexistence of both metabolic pathways for 
glucose reflects either normal cells intermixed with those 
affected by increased substrate demand or recovering cells 
that cannot utilize fatty acids but have a functioning citric 
cycle with preferential use of glucose and lactate as sub- 
strates. Previous studies using “C-palmitate in the same 
model indicated impaired long chain fatty acid metabolism in 
areas with increased glucose utilization, as evidenced by 
“F-deoxyglucose uptake (11). These findings would support 
the hypothesis of metabolically altered, recovering cells. It is 
possible that the enzymatic environment is altered in isch- 
emically injured myocardium, with glucose becoming the 
preferred substrate for oxidative metabolism. Increased glu- 
cose oxidation has been described in postischemic skeletal 
muscle and attributed to a metabolic adaptation to repetitive 
ischemia (31). 
On the other hand, the inverse relation of plasma nones- 
terified fatty acid levels with glucose oxidation noted in our 
experiments suggest an intact regulatory mechanism of 
oxidative substrate metabolism in reperfused myocardium 
(14). This characteristic of the reperfused tissue may reflect, 
primarily, the metabolism of an intermixed normal cell 
population, most likely in the subepicardium that can utilize 
both fatty acids and glucose. 
Conclusions 
This study demonstrates that enhanced nonoxidative 
glycolysis is still occurring after 24 h of reperfusion following 
a severe (3 h) ischemic insult to the myocardium. The 
observed increased exogenous glucose utilization confirms 
earlier findings of increased “F-deoxyglucose uptake iden- 
tified in the same model by positron emission tomographic 
imaging. Both histochemical and metabolic data demon- 
strated heterogeneity of injury in the risk area. Metabolically 
and histochemically normal cells coexist with severely com- 
promised and necrotic myocytes. The methods employed in 
this investigation do not provide enough spatial resolution to 
allow specific metabolic characterization on a cellular level. 
The relation between glucose extraction and lactate produc- 
tion in the reperfused territory indicates that sustained 
nonoxidative glycolysis is dependent on the exogenous 
glucose supply in the presence of depleted glycogen stores. 
Assuming a beneficial effect of nonoxidative glycolysis for 
tissue recovery, these findings demonstrate the importance 
of exogenous glucose for substrate metabolism in post- 
ischemic myocardium. 
Therefore, our metabolic observations may have impor- 
tant future implications for the development of therapeutic 
strategies in patients with acute myocardial infarction. 
Recent clinical studies of this patient group with the use of 
PET revealed increased ‘8F-deoxyglucose uptake in “in- 
farcted” myocardium studies several days after the acute 
event (32,33). These clinical findings suggest a similar met- 
abolic pattern in both the canine and human heart after an 
ischemic injury. Therefore, PET in combination with tracers 
such as “F-deoxyglucose, will allow metabolic characteri- 
zation of tissue injury and may provide a noninvasive means 
of studying tissue recovery and the effects of therapeutic 
interventions on metabolism in ischemically injured human 
myocardium. 
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